UK – NICE updates guideline on atrial fibrillation

The UK’s National Institute for Health and Care Excellence has published an updated clinical guideline on the diagnosis and management of atrial fibrillation (AF) addressing several areas of new evidence.

The updated guideline includes new evidence since the publication of NICE’s previous guideline in 2014.

This includes the use of tools to calculate the risk of bleeding when considering the use of anticoagulants, the role of newer anti-clotting drugs and the use of treatments that aim to destroy/isolate the abnormal source of electrical impulses in the heart that may drive AF.

In a statement, NICE said that accurate knowledge of bleeding risk supports shared decision and also has practical benefit.

In addition, evidence has shown that a tool known as ORBIT is the most accurate for predicting the risk of bleeding in people with AF…